Endo - Home | Introducing Keenova and Par Health
Mallinckrodt and Endo are merging to create a leading global therapeutics company with branded and generic products. Stay tuned for updates.
Mallinckrodt and Endo to Combine to Create a Global, Scaled ...
Mar 13, 2025 · Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after the close of the transaction and intend to separate that …
Endo Completes International Pharmaceuticals Business Divestiture
Jun 17, 2025 · Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these …
Mallinckrodt and Endo Announce Significant Progress in Proposed …
As announced on March 13, 2025, the proposed Mallinckrodt and Endo transaction envisions the spin-off of the combined generic pharmaceuticals businesses and Endo's sterile injectables business into …
Endo Reports First-Quarter 2025 Financial Results and Reaffirms 2025 ...
Mar 31, 2025 · Copies of the Company's press releases and additional information about the Company are available at www.endo.com or you can contact the Company's Investor Relations Department at …
Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results
Mar 13, 2025 · Endo is providing the following financial guidance for the full year ending December 31, 2025 based on Endo's current views, beliefs, estimates and assumptions.
Investors | Endo - Overview
Oct 9, 2025 · Mallinckrodt and Endo have merged to create a global, scaled, diversified therapeutics leader. Visit our new Investor Relations website at ir.mallinckrodt.com for up-to-date investor …
Endo Announces Divestiture of International Pharmaceuticals Business
Mar 11, 2025 · Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these …
Investors | Endo - Press Releases
Aug 1, 2025 · Goldman Sachs & Co. LLC served as Endo's financial advisor; Davis Polk & Wardwell LLP served as Endo's lead counsel; and Paul, Weiss, Rifkind, Wharton & Garrison LLP and A&L …
Mallinckrodt, Endo Announce Planned Leadership Team for Merged …
Jun 9, 2025 · Mallinckrodt and Endo commenced mailing of the definitive joint proxy statement/prospectus to shareholders of Mallinckrodt and Endo, respectively, on or about May 12, …